NCT01386190

Brief Summary

This research consists of a novel intervention designed to increase physical activity of premature babies in their first year of life. The potential beneficial impact of augmented physical activity on:

  1. 1.Body composition
  2. 2.Associated biochemical and cellular mechanisms of growth and inflammation
  3. 3.Quality of maternal care will be measured

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jun 2011

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2011

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

June 21, 2011

Completed
9 days until next milestone

First Posted

Study publicly available on registry

June 30, 2011

Completed
Last Updated

January 25, 2021

Status Verified

January 1, 2021

Enrollment Period

Same day

First QC Date

June 21, 2011

Last Update Submit

January 22, 2021

Conditions

Keywords

preterm infant, body composition, exercise

Outcome Measures

Primary Outcomes (1)

  • Change in Lean Body Mass (LBM) as assessed by Dual X-ray Absorbiometry(DXA) at age 34-40 weeks gestational age and 86-92 weeks of age

    LBM (lean body mass) will be measured and compared at the UCI Institute for Clinical and Translational Science. Dual X-ray Absorbiometry (DXA) scan to measure lean mass will be done using a whole body fan-beam scanner (Hologic QDR Discovery-A Hologic Inc., Bedford MA)at age 34-40 weeks gestational age and again at 86-92 weeks of age

    ages: 34-40 weeks gestational age and 86 - 92 weeks of age

Secondary Outcomes (6)

  • Blood sample

    ages: 34-40 weeks gestational age and 86 - 92 weeks of age

  • Energy Expenditure 1 Accelerometer three time points in the study

    ages: 34-40 weeks gestational age, 52-68 weeks and 86 - 92 weeks of age

  • Energy expenditure 2 Total Energy Expenditure as assessed by Doubly Labeled Water

    age: 86-92 weeks

  • Diet Assessments

    ages: 34-40 weeks gestational age, 52-68 weeks and 86 - 92 weeks of age

  • Quality of Caregiver-Child Interaction

    ages: 34-40 weeks gestational age and 86 to 92 weeks of age

  • +1 more secondary outcomes

Study Arms (2)

Exercise Group

EXPERIMENTAL

Caregivers will be taught progressive exercises to use with their infants from hospital discharge to 1 year of age.

Other: Exercise/Social Behavioral

Control

ACTIVE COMPARATOR

Both the control and the intervention groups will be guided in implementing structured social interaction.In the control group, the structured interaction will consist of predominantly social activities such as the caregiver reading or singing to the baby. The duration of the structured activities for both groups will be the same.

Other: Exercise/Social Behavioral

Interventions

Both the control and the intervention groups will be guided in implementing structured social interaction. In the intervention group, the structured interaction will incorporate augmented physical activities, while in the control group, the structured interaction will consist of predominantly social activities such as the caregiver reading or singing to the baby. The duration of the structured activities for both groups will be the same.

ControlExercise Group

Eligibility Criteria

Age29 Weeks - 34 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Infant is a healthy, growing NICU inpatient.
  • Caregiver ≥18 years of age
  • Infant gestational age at birth \<29weeks
  • Infant gestational age at time of study recruitment \>34 wks, on full feeds and nearing discharge

You may not qualify if:

  • Significant lung disease of prematurity requiring supplemental oxygen or corticosteroids at discharge
  • Significant intraventricular hemorrhage, grade III -IV
  • Necrotizing entrocolitis
  • Tracheostomy
  • Bone Diseases
  • Osteogenesis Imperfecta
  • Hip or knee joint anomalies
  • Arthrogryposis
  • Fractures
  • Skin disorders (e.g., Erythematus Bullosis)
  • Symptomatic congestive heart disease
  • Any other conditions or congenital anomalies likely to severely impact the ability of the premature baby and caregiver to participate in a demanding study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Irvine Douglas Hospital

Orange, California, 92868, United States

Location

MeSH Terms

Conditions

Glucocorticoid Receptor DeficiencyPremature BirthMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

Obstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Dan M. Cooper, MD

    University of California, Irvine

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 21, 2011

First Posted

June 30, 2011

Study Start

June 1, 2011

Primary Completion

June 1, 2011

Study Completion

June 1, 2011

Last Updated

January 25, 2021

Record last verified: 2021-01

Locations